At SEC, Arrhythmia Research misses a beat

Bloomberg News/File 2007

Fitchburg-based Arrhythmia Research’s software analyzes the heart’s electrical impulses.

Arrhythmia Research Technology Inc. announced on Tuesday that it was unable to file its annual Form 10-K report with the Securities and Exchange Commission for the fiscal year ended Dec. 31, despite an extension to April 16. The delay is due to an ongoing internal audit relating to adjustments to the calculation of tax-deferred assets in the company’s Canadian subsidiary, RMDDx Corp. Said chief executive James E. Rouse: “We want our stockholders to know that it is of paramount importance to us to provide confidence and transparency in our financial statements and that we are doing everything possible to ensure that this a one-time only event.’’

Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
We hope you've enjoyed your free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of